Table 1.
Clinicopathological features of the study population
Clinicopathologic Characteristics | |
---|---|
Age at diagnosis (years) | |
Median (range) | 62 (30–80) |
Histology (n (%)) | |
Ductal | 44 (90%) |
Lobular | 5 (10%) |
Histologycal grade (n (%)) | |
I and II | 39 (80%) |
III | 10 (20%) |
UICC stage (n (%)) | |
IIB | 6 (12%) |
IIIA + IIIB | 11 (22%) |
IV | 32 (65%) |
ER status (n (%)) | |
positive | 49 (100%) |
negative | 0 (0%) |
PR status(n (%)) | |
positive | 33 (67%) |
negative | 16 (33%) |
HER2 status (n(%)) | |
positive | 8 (16%) |
negative | 41 (84%) |
Abbreviations: ER estrogen receptor, PR progesterone receptor, HER2 erb-b2 receptor tyrosine kinase 2, UICC Union for International Cancer Control